Systemic Transthyretin Amyloidosis: Carpal Tunnel Syndrome in a Portuguese Population
NCT ID: NCT05409833
Last Updated: 2023-10-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
100 participants
OBSERVATIONAL
2020-06-01
2025-06-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Transthyretin Cardiac Amyloidosis in Patients With Idiopathic Carpal Tunnel Syndrome Referred for Release Surgery
NCT04611204
Carpal Tunnel Syndrome and Amyloid Cardiomyopathy
NCT02792790
Carpal Tunnel Syndrome and Amyloidosis
NCT04245098
Carpal Tunnel Release With Risk Factors for Amyloidosis
NCT05793320
Prevalence of Amyloidosis and Carpal Tunnel
NCT02152644
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group 1
Patients aged ≥ 60 years old with symptomatic carpal tunnel syndrome submitted to surgery
Synovial biopsy and Cardiac scintigraphy with [99mTc]Tc-DPD
Congo red and Immunohistochemical analysis and/or Mass spectrometry analysis
Group 2
Patients aged ≥ 60 years old without symptomatic carpal tunnel syndrome submitted to hand surgery
Synovial biopsy and Cardiac scintigraphy with [99mTc]Tc-DPD
Congo red and Immunohistochemical analysis and/or Mass spectrometry analysis
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Synovial biopsy and Cardiac scintigraphy with [99mTc]Tc-DPD
Congo red and Immunohistochemical analysis and/or Mass spectrometry analysis
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centro Hospitalar De São João, E.P.E.
OTHER
Centro de Investigação em Tecnologias e Serviços de Saúde
OTHER
Rede de Investigação em Saúde
OTHER
Universidade do Porto
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Elisabete Martins, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Universidade do Porto
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centro Hospitalar Universitário São João
Porto, , Portugal
Faculty of Medicine (FMUP)
Porto, , Portugal
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CarPoS
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.